Pharmacological Interventions versus Combined Treatment of Depression: A Prospective Study

• Published in: Psychopharmacology bulletin Vol. 52; no. 4; pp. 69 - 84
• Main Authors: Caselli, I, Bellini, A, Colombo, S, Ielmini, M, Callegari, C
• Format: Journal Article
• Language: English
• Published: United States MedWorks Media Global 27.10.2022
• Subjects: Anxiety Disorders; Combined Modality Therapy; Depression; Female; General Psychiatry; Humans; Male; Prospective Studies; Psychotherapy - methods; combined treatment; pharmacological interventions; depression; prospective study
• ISSN: 0048-5764; 2472-2448

Depression is a common disease worldwide but still, the role of combined treatment (pharmacological and psychological interventions) needs to be clarified. The study aims to compare the effectiveness of integrated treatment versus exclusive pharmacological intervention of depression. The observational prospective study provided the collection of data relating to outpatients evaluated through the administration of the Hamilton Depression Rating Scale (HDRS), the Hamilton Anxiety Rating Scale (HARS), and the Clinical Global Impression Scale (CGI) both at T0 and at a 3-month follow up visit (T1). A statically significant association between sex (female) and psychotherapy utilization emerged. A statistically significant association between education (graduated patients) and psychotherapy use was observed. The other qualitative variables showed no statistically significance associations. No significant association between drop out and type of treatment emerged. Clinical research has not yet conclusively demonstrated the superiority of combined therapy over single treatments. As regards sex, the result is in line with the professional literature and provides support in describing how men have more stigmatizing beliefs about treatment of mental health. As regards education, graduated people present higher rates of adherence probably because they may have major introspective capacity and predisposition to communication. Limitations consist in small sample and short duration of the follow-up (3 months). The strengths, in the type of setting and the respect for routine clinical practice. Future perspective of the research could focus on application of rating instruments to highlight the variables involved in depressive disorder.